Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1148330 | 0.81 | GABRA1 (0.52) | GABRA1GABRB2LMNAFAAHCA1 | |
| SCHEMBL9864537 | 0.81 | GABRA1 (0.52) | GABRA1GABRB2LMNAFAAHCA1 | |
| SCHEMBL3103286 | 0.79 | GABRA1 (0.48) | GABRA1GABRB2LMNAFAAHCA1 | |
| SCHEMBL1635308 | 0.79 | GABRA1 (0.50) | GABRA1GABRB2LMNAFAAHCA1 | |
| SCHEMBL29567244 | 0.79 | GABRA1 (0.50) | GABRA1GABRB2LMNAFAAHCA1 | |
| Benzene SCHEMBL28132022 | 0.79 | ALDH1A1 (0.59) | GABRA1GABRB2LMNAFAAHCA1 | |
| Hydrogen Peroxide SCHEMBL9514730 | 0.79 | ALDH1A1 (0.59) | GABRA1GABRB2LMNAFAAHCA1 | |
| SCHEMBL29657201 | 0.79 | ALDH1A1 (0.59) | GABRA1GABRB2LMNAFAAHCA1 | |
| SCHEMBL254364 | 0.79 | ALDH1A1 (0.59) | GABRA1GABRB2LMNAFAAHCA1 | |
| SCHEMBL2153533 | 0.77 | ALDH1A1 (0.50) | GABRA1GABRB2LMNAFAAHCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109476616-B | Piperazinyl methanone NAAA inhibitors | 加利福尼亚大学董事会 | 2023-10-13 | — | — | CN | disclosed |
| US-20120219885-A1 | NOVEL NON-CRYSTALLIZING METHACRYLATES, PRODUCTION AND USE THEREOF | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2012-08-30 | — | — | US | disclosed |
| US-5597779-A | HERBICIDES | CIBA-GEIGY CORPORATION (US) | 1997-01-28 | — | — | US | disclosed |
| US-5552368-A | Sulfonylureas | CIBA-GEIGY CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
| US-5519148-A | CHEMICAL INTERMEDIATES FOR HERBICIDES | CIBA-GEIGY CORPORATION (US) | 1996-05-21 | — | — | US | disclosed |
| EP-0496701-B1 | Sulfonylureas as herbizides | CIBA GEIGY AG (CH) | 1996-03-06 | — | — | EP | disclosed |
| US-5489695-A | PREEMERGENCE, POSTEMERGENCE HERBICIDES | CIBA-GEIGY CORPORATION (US) | 1996-02-06 | — | — | US | disclosed |
| EP-0480871-B1 | Synergistic agents and method for selective control of weeds | CIBA GEIGY AG (CH) | 1995-12-13 | — | — | EP | disclosed |
| US-5412107-A | Phenylsulfonylchloride intermediates useful for the preparation of herbicidally active sulfonylureas | CIBA-GEIGY CORPORATION (US) | 1995-05-02 | — | — | US | disclosed |
| EP-0626958-A1 | SULFONYLUREAS AS HERBICIDES | CIBA-GEIGY AG (CH) | 1994-12-07 | — | — | EP | disclosed |
| US-5310722-A | Synergistic composition comprising a sulfonylurea and a thiadiazolo[3,4-a]py | CIBA-GEIGY CORPORATION (US) | 1994-05-10 | — | — | US | disclosed |
| US-5286709-A | Sulfonylureas | CIBA-GEIGY CORPORATION (US) | 1994-02-15 | — | — | US | disclosed |
| WO-1993017016-A1 | SULFONYLUREAS AS HERBICIDES | CIBA-GEIGY AG (CH) | 1993-09-02 | — | — | WO | disclosed |
| US-5209771-A | Herbicides | CIBA-GEIGY CORPORATION (US) | 1993-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120219885-A1 | NOVEL NON-CRYSTALLIZING METHACRYLATES, PRODUCTION AND USE THEREOF | MEP1A, MMAB, RHOA | GABRA1 3955/4885GABRB2 4640/4885LMNA 2413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.